Spain · Delayed Price · Currency is EUR CLERHP Estructuras Statistics
Total Valuation
BME:CLR has a market cap or net worth of EUR 212.83 million. The enterprise value is 228.60 million.
| Market Cap | 212.83M |
| Enterprise Value | 228.60M |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:CLR has 18.04 million shares outstanding.
| Current Share Class | 18.04M |
| Shares Outstanding | 18.04M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.92% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.51% |
| Float | 9.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.57 |
| PS Ratio | 15.04 |
| PB Ratio | 13.39 |
| P/TBV Ratio | 13.55 |
| P/FCF Ratio | 943.08 |
| P/OCF Ratio | 221.43 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.38, with an EV/FCF ratio of 1,012.98.
| EV / Earnings | n/a |
| EV / Sales | 16.16 |
| EV / EBITDA | 32.38 |
| EV / EBIT | 38.45 |
| EV / FCF | 1,012.98 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 1.00.
| Current Ratio | 1.24 |
| Quick Ratio | 0.30 |
| Debt / Equity | 1.00 |
| Debt / EBITDA | 2.24 |
| Debt / FCF | 70.19 |
| Interest Coverage | 2.03 |
Financial Efficiency
Return on equity (ROE) is -7.41% and return on invested capital (ROIC) is -2,540.93%.
| Return on Equity (ROE) | -7.41% |
| Return on Assets (ROA) | 4.45% |
| Return on Invested Capital (ROIC) | -2,540.93% |
| Return on Capital Employed (ROCE) | 24.49% |
| Weighted Average Cost of Capital (WACC) | -120.17% |
| Revenue Per Employee | 155,458 |
| Profits Per Employee | -10,679 |
| Employee Count | 91 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:CLR has paid 975,598 in taxes.
| Income Tax | 975,598 |
| Effective Tax Rate | 10,226.39% |
Stock Price Statistics
The stock price has increased by +237.14% in the last 52 weeks. The beta is 1.11, so BME:CLR's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +237.14% |
| 50-Day Moving Average | 9.27 |
| 200-Day Moving Average | 6.44 |
| Relative Strength Index (RSI) | 76.54 |
| Average Volume (20 Days) | 13,148 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:CLR had revenue of EUR 14.15 million and -971,806 in losses.
| Revenue | 14.15M |
| Gross Profit | 15.06M |
| Operating Income | 5.95M |
| Pretax Income | 9,540 |
| Net Income | -971,806 |
| EBITDA | 7.06M |
| EBIT | 5.95M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 8.04 million in cash and 15.84 million in debt, with a net cash position of -7.80 million or -0.43 per share.
| Cash & Cash Equivalents | 8.04M |
| Total Debt | 15.84M |
| Net Cash | -7.80M |
| Net Cash Per Share | -0.43 |
| Equity (Book Value) | 15.89M |
| Book Value Per Share | n/a |
| Working Capital | 17.59M |
Cash Flow
In the last 12 months, operating cash flow was 961,128 and capital expenditures -735,456, giving a free cash flow of 225,672.
| Operating Cash Flow | 961,128 |
| Capital Expenditures | -735,456 |
| Depreciation & Amortization | 1.11M |
| Net Borrowing | 5.70M |
| Free Cash Flow | 225,672 |
| FCF Per Share | 0.01 |
Margins
Gross margin is 106.46%, with operating and profit margins of 42.03% and -6.87%.
| Gross Margin | 106.46% |
| Operating Margin | 42.03% |
| Pretax Margin | 0.07% |
| Profit Margin | -6.87% |
| EBITDA Margin | 49.90% |
| EBIT Margin | 42.03% |
| FCF Margin | 1.60% |
Dividends & Yields
BME:CLR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.46% |
| FCF Yield | 0.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for BME:CLR is 10.30, which is -12.71% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | 10.30 |
| Price Target Difference | -12.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 192.72% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |